Hims & Hers Health (HIMS) Stock Price, Quote, News & History | Benzinga

Hims & Hers Health Inc (HIMS) Stock Price, Quote, News & History

HIMSNYSE

Trade with Public

Trade with Public

$31.59

1.936.51%

At close: Aug 7, 5:00 PM EST

$31.67

0.080.25%

After Hours: Aug 7, 7:59 PM EST

Earnings: Q2 2026 earnings tomorrow on Mon Aug 10th after the market close

Conference Call: Conference call scheduled tomorrow at 5:00 PM

Click to view the webcast

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$30.19

Close

$31.59

Volume / Avg.

8.39M / 18.62M

Day Range

$29.80 - $31.72

52 Wk Range

13.74 - 65.30

Market Cap

$7.33B

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

51

Short Interest

31.94%

Days to Cover

4.52

Recent Hims & Hers Health, Inc. News

Hims & Hers Shares Rebound Friday: What's Driving the Move?

Hims & Hers Health shares are trading higher Friday as traders continue to weigh fresh regulatory scrutiny against a generally risk-on tape.

Henry Khederian

Hims & Hers May Face FTC Lawsuit for Allegedly Sharing Sensitive User Data With Advertisers: Report

The FTC is suing Hims & Hers for allegedly sharing user health data with advertisers and engaging in deceptive billing practices.

Vandana Singh

Jim Cramer: Arista Is ‘Terrific,’ Also Likes This Consumer Cyclical Stock

Jim Cramer likes Ross Stores (ROST) on CNBC's Mad Money Lightning Round. Ross Stores reported strong earnings and raised guidance. Arista Networks (ANET) is also favored.

Avi Kapoor

FDA Panel Narrowly Backs Four Peptides — Hims & Hers Stock in the Spotlight

Hims & Hers Health is in focus Friday after an FDA advisory panel on Thursday recommended adding four peptides to a federal compounding list.

Dylan Berman

QUICK SPARK: Martin Shkreli Shorts Hims & Hers Stock, Says 'Peptides Are Fake Medicine'

Martin Shkreli shorts Hims & Hers stock, calling its peptides fake medicine.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

280.27M

Investing Cash Flow (TTM)

-1.01B

Financing Cash Flow (TTM)

674.76M

Free Cash Flow (TTM)

60.40M

Capital Expenditure (TTM)

-219.88M

Net Change in Cash (TTM)

-52.58M

Analyst Trends and Forecast

1

2

Apr

2

5

May

1

Jun

1

3

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.9

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$7.69B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.17

PB Ratio (TTM)

15.39

Earnings Yield % (TTM)

-0.30%

Earnings Yield % (FWD)

-0.37%

EV / EBITDA (TTM)

192.86

Price / EBITDA (TTM)

200.25

Price / Free Cash Flow (TTM)

124.58

Book Value / Share

$1.93

Company Debt

Total Debt

$974.11M

LT Debt

$974.11M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$222.27M

Debt to Equity

2.54

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$30.19

Close

$31.59

Volume / Avg.

8.39M / 18.62M

Day Range

$29.80 - $31.72

52 Wk Range

13.74 - 65.30

Market Cap

$7.33B

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

51

Short Interest

31.94%

Days to Cover

4.52

About

Sector

Health Care

Industry

Health Care Providers & Services

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Hims & Hers Health (HIMS) stock?

A

You can purchase shares of Hims & Hers Health (NYSE:HIMS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Hims & Hers Health (HIMS) competitors?

A

Other companies in Hims & Hers Health’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Quest Diagnostics Inc (NYSE:DGX), Labcorp Holdings Inc (NYSE:LH) and Guardant Health Inc (NASDAQ:GH).

Q

What is the forecast, or price target, for Hims & Hers Health (HIMS) stock?

A

Hims & Hers Health has a consensus price target of $28.35.

Q

What is the current price for Hims & Hers Health (HIMS)?

A

The stock price for Hims & Hers Health (NYSE: HIMS) is $31.67 last updated August 7, 2026 at 7:59 PM EDT.

Q

Does Hims & Hers Health (HIMS) pay a dividend?

A

There are no upcoming dividends for Hims & Hers Health.

Q

When is Hims & Hers Health (NYSE:HIMS) reporting earnings?

A

Hims & Hers Health does not have any upcoming earnings scheduled.

Q

Is Hims & Hers Health (HIMS) going to split?

A

There is no upcoming split for Hims & Hers Health.

Q

What sector and industry does Hims & Hers Health (HIMS) operate in?

A

Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.